Ahmed A. Abd-Elrahman

Ahmed A. Abd-Elrahman

Auto-generated profile, based on publicly available information

Ahmed A. Abd-Elrahman

Neuropsychiatry Department, Faculty of Medicine, Assiut University, Assiut, Egypt

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2016 in Drug Delivery
Verified
Journal Article
Open access
AAAhmed A. Abd-Elrahman
Ahmed A. Abd-Elrahman
MNMohamed A. El Nabarawi
Mohamed A. El Nabarawi
DHDoaa Hussien Hassan
Doaa Hussien Hassan
AAAmal ANWAR Anwar
Amal ANWAR Anwar
SBA-15 is used to enhance the bioavailability of poorly soluble ketoprofen (KP) through stabilization of its amorphous state. Additionally, the current work provides a complete in vitro and in vivo study on preformulated KP-SBA-15 sample and formulated KP-SBA-15 in hard gelatin capsule. Loading of KP was done by a novel method called immersion-rotavapor method. KP was quantified by extraction and thermal gravimetric analysis (TGA). Characterization of the loaded SBA-15 sample was done by high resolution transmission electron microscopy (HRTEM), small angle X-ray diffraction (SAXRD), nitrogen adsorption/desorption isotherms, differential scanning calorimetry (DSC), Fourier transform infrared (FT-IR) spectroscopy and dissolution profiles. The loaded sample was formulated in hard gelatin capsule. The anti-inflammatory and analgesic studies were carried out on 24 adult male albino rats. TGA and extraction results showed 54.4 wt% of drug incorporated. Characterization of KP-SBA-15 sample confirmed the successful encapsulation of KP into the carrier pores in a molecular amorphous state. Additionally, loading of KP did not affect the mesoporous internal structure. During the first 5 min, the dissolution study showed very high release rates; nearly 50% of KP was released. These results were reflected on the in vivo study resulting in 82% inhibition in edema after 1 h and maximum analgesia after 30 min from the administration of the formulated sample. SBA-15 mesoporous silica nanoparticle proved to be a very promising drug delivery carrier that can be used as a facile way to enhance the bioavailability of poorly soluble drugs.


1 June 2021 in Neurophysiologie Clinique
Verified
Journal Article
Closed access
EKEman M Khedr
Eman M Khedr
AAAhmed A. Abdelrahman
Ahmed A. Abdelrahman
SSShady M. Safwat
Shady M. Safwat
AMAmira Moheb
Amira Moheb
MNMostafa M. Noaman
Mostafa M. Noaman